{
    "organizations": [],
    "uuid": "b44580fd7e34e5c217a7ab20361d538c9d57eac6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-biohaven-says-us-fda-has-notified/brief-biohaven-says-u-s-fda-has-notified-co-it-may-proceed-with-clinical-investigation-of-bhv-5000-idUSFWN1PD06Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Biohaven says U.S. FDA has notified co it may proceed with clinical investigation of BHV-5000",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 10 AM / Updated 14 minutes ago BRIEF-Biohaven says U.S. FDA has notified co it may proceed with clinical investigation of BHV-5000 Reuters Staff \nJan 18 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd: \n* BIOHAVEN ANNOUNCES INITIATION OF CLINICAL DEVELOPMENT FOR BHV-5000, A NOVEL LOW-TRAPPING NMDA ANTAGONIST \n* BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD- U.S. FOOD AND DRUG ADMINISTRATION HAS NOTIFIED CO IT MAY PROCEED WITH CLINICAL INVESTIGATION OF BHV-5000â€‹ Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T10:10:00.000+02:00",
    "crawled": "2018-01-18T10:38:04.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "say",
        "fda",
        "notified",
        "co",
        "may",
        "proceed",
        "clinical",
        "investigation",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "biohaven",
        "pharmaceutical",
        "holding",
        "company",
        "ltd",
        "biohaven",
        "announces",
        "initiation",
        "clinical",
        "development",
        "novel",
        "nmda",
        "antagonist",
        "biohaven",
        "pharmaceutical",
        "holding",
        "company",
        "food",
        "drug",
        "administration",
        "notified",
        "co",
        "may",
        "proceed",
        "clinical",
        "investigation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}